1 study found for:    14661009 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Candesartan for Prevention of Cardiovascular Events After Cypher or Taxus Coronary Stenting (4C) Trial
Conditions: Hypertension;   Coronary Artery Disease
Intervention: Drug: Candesartan

Indicates status has not been verified in more than two years